Related Experiment Video
Updated: Jul 10, 2026

04:33
CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
Published on: December 8, 2023
A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery
Josep Villanueva1, Arpi Nazarian, Kevin Lawlor
1Protein Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Molecular & Cellular Proteomics : MCP
|November 8, 2007
Summary
This study introduces a novel assay to measure exoprotease activity in biological samples. The assay accurately distinguishes metastatic thyroid cancer patients from healthy controls, demonstrating high sensitivity and specificity.
Area of Science:
- Biochemistry
- Proteomics
- Analytical Chemistry
Background:
- Functional proteomics aims to measure actual biological activities, not just protein states.
- Exoprotease activity profiling is crucial for understanding complex biological processes and disease states.
Purpose of the Study:
- To present a novel assay for comparing exoprotease activities across different biological sample groups.
- To establish a reproducible method for assessing enzyme-catalyzed reactions in complex matrices.
Main Methods:
- Utilizes artificial substrates and semiautomated MALDI-TOF mass spectrometry to track substrate degradation.
- Employs double-labeled, non-degradable internal standards for accurate quantitation of fragments.
- Applies multivariate statistical analysis to quantitated metabolite arrays.
Main Results:
- Achieved high reproducibility with coefficients of variation between 6.3-14.3% over five replicates.
- Successfully differentiated 48 metastatic thyroid cancer patients from 48 healthy controls.
- Obtained class predictions with 94% sensitivity and 90% specificity using 24 features.
Conclusions:
- The developed assay effectively measures exoprotease activity and distinguishes cancer patients from controls.
- The method minimizes reproducibility issues associated with sample handling and endogenous variations.
- This approach offers a robust tool for biomarker discovery and disease diagnostics.

